We are live on ! Find out more
ITOS

iTeos Therapeutics
ITOS

Delisted

ITOS was delisted on the 28th of August, 2025.

Back to rankings

71 hedge funds and large institutions have $907M invested in iTeos Therapeutics in 2020 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

340% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 5

100% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 12

48% more capital invested

Capital invested by funds: $614M → $907M (+$292M)

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

31% more funds holding

Funds holding: 54 → 71 (+17)

5.55% more ownership

Funds ownership: 71.2% → 76.75% (+5.5%)

Holders
71
Holders Change
+17
Holders Change %
+31.48%
% of All Funds
1.26%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
22
Increased
24
Reduced
12
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$26.2M
2
BlackRock
BlackRock
New York
+$10.7M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$8.74M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$8.65M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$5.97M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$10M
2
APM
Avidity Partners Management
Texas
-$6.29M
3
SFM
Sphera Funds Management
Israel
-$6.17M
4
LGM
Logos Global Management
California
-$5.29M
5
Citadel Advisors
Citadel Advisors
Florida
-$2.67M
Name Holding Trade Value Shares
Change 		Change in
Stake
Franklin Resources
26
Franklin Resources
California
$2.88M – – –
Charles Schwab
27
Charles Schwab
California
$2.53M +$149K +5,610 +8%
Wellington Management Group
28
Wellington Management Group
Massachusetts
$2.07M +$1.62M +61,300 New
Goldman Sachs
29
Goldman Sachs
New York
$2.05M +$906K +34,227 +129%
N
30
Nuveen
North Carolina
$1.86M +$857K +32,361 +143%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.4M +$323K +12,191 +42%
CS
32
Credit Suisse
Switzerland
$1.13M +$887K +33,496 New
Man Group
33
Man Group
United Kingdom
$944K -$331K -12,519 -31%
Swiss National Bank
34
Swiss National Bank
Switzerland
$937K +$733K +27,700 New
MS
35
Maven Securities
Jersey
$844K +$660K +24,924 New
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$801K -$13.2K -500 -2%
HS
37
HighVista Strategies
Massachusetts
$605K +$473K +17,880 New
AC
38
Athanor Capital
New York
$600K +$469K +17,727 New
California State Teachers Retirement System (CalSTRS)
39
California State Teachers Retirement System (CalSTRS)
California
$573K +$20.4K +770 +5%
Millennium Management
40
Millennium Management
New York
$535K +$419K +15,809 New
State of Wisconsin Investment Board
41
State of Wisconsin Investment Board
Wisconsin
$507K +$397K +15,000 New
CF
42
CNA Financial
Illinois
$428K +$98.2K +3,710 +41%
RhumbLine Advisers
43
RhumbLine Advisers
Massachusetts
$356K +$49.6K +1,875 +22%
SFI
44
Susquehanna Fundamental Investments
Pennsylvania
$336K -$99.8K -3,769 -28%
VEA
45
Virtus ETF Advisers
New York
$335K +$263K +9,916 New
DekaBank Deutsche Girozentrale
46
DekaBank Deutsche Girozentrale
Germany
$330K +$265K +10,000 New
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$328K +$127K +4,800 +98%
Morgan Stanley
48
Morgan Stanley
New York
$286K +$161K +6,078 +256%
Deutsche Bank
49
Deutsche Bank
Germany
$270K +$60K +2,267 +40%
ProShare Advisors
50
ProShare Advisors
Maryland
$267K +$209K +7,886 New
1
2
3 4

ITOS Hedge Fund Activity: Q4 2020 in Review

71 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in iTeos Therapeutics (ITOS) for Q4 2020, worth a combined $907M — up 48% from $614M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new ITOS positions and 5 closed out — a net gain of 17 holders — while 24 added to existing stakes and 12 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $26.2M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $10M sold.

  • 71 institutional investors held iTeos Therapeutics (ITOS) as of Q4 2020, up from 54 in Q3 2020.
  • Funds reported $907M of iTeos Therapeutics stock for Q4 2020, up 48% quarter-over-quarter.
  • 22 funds opened new iTeos Therapeutics positions in Q4 2020 and 5 closed out, a net change of +17 holders.
  • The largest iTeos Therapeutics buyer in Q4 2020 was Janus Henderson Group, an estimated $26.2M added.
  • The largest iTeos Therapeutics seller in Q4 2020 was PFM Health Sciences, an estimated $10M sold.

Based on aggregated 13F filings for Q4 2020.